世界におけるがん免疫療法及びパイプラインインサイト

調査会社Kuick Research社が発行したリサーチレポート(データ管理コード:KUK40723)
◆英語タイトル:Cancer Immunotherapy Market & Clinical Pipeline Insight
◆発行会社/調査会社:Kuick Research
◆商品コード:KUK40723
◆発行日:2014年7月
◆調査対象地域:グローバル
◆産業分野:医療
◆ページ数:1990
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD3,000 ⇒換算¥339,000見積依頼/購入/質問フォーム
Multi User(社内共有可)USD6,000 ⇒換算¥678,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
Kuick Research社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[世界におけるがん免疫療法及びパイプラインインサイト]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

With more than 6 million deaths worldwide in 2013, cancer has become one of the most pressing health problems faced by almost all the economies of the world. Inspite of the fact that there have been significant improvisation and advancements in surgery, radiation therapy, and chemotherapy over the years, there has hardly been any significant control of this disease by these treatments. There have been many developments in the recent past, in terms of introducing novel methods of treatment of cancer, which are likely to have a great potential. Cancer immunotherapy is one such development in the field of cancer treatment. This treatment option involves manipulating the human body’s immune system in order to target the cancer.

The recent years have witnessed the emergence of cancer immunotherapy, which has the potential to offer less toxic and more efficient therapeutic alternatives for patients. Over the past 15-20 years, the researchers have increased their learning about the human body’s immune system, which has led to the achievement of significant number of regulatory milestones during this period. Cancer immunotherapy has been made commercial and the market availability of the agents has enabled the pharmaceutical companies to develop novel combination approaches which have the capability to provide even greater insight into the body’s immune system.

There has been some extensive research in the previous decade which has led to the development of vital novel therapies for diseases such as bladder cancer, renal cell carcinoma, colon cancer, and some leukemias. Additionally, these significant achievements in cancer immunotherapy have been popular on similar lines as improved techniques such as genetic engineering and monoclonal antibody generation. Thus, both these set of advancements have been working hand-in-hand to bring the cancer immunotherapy on the growth trajectory. The future is also likely to witness a continued close association between these two fields of advancements.

Cancer immunotherapy will continue to be overflowing with huge potential as a result of an increasing number of new discoveries and techniques. Inspite of advances being made in terms of understanding of the complexities of the human immune system, as compared to the state of immunology during Dr. Coley, there is still significant work which needs to be done. The complete detailed understanding is yet to be deciphered, which is one of the major reasons for cancer immunotherapy not being in widespread use.

“Cancer Immunotherapy Market & Clinical Pipeline Insight” Report Highlights:
• Cancer Immunotherapy Market Overview
• Cancer Immunotherapy Market Dynamics
• Cancer Immunotherapy Pipeline: 1080 Drug in Clinical Pipeline
• Cancer Monoclonal Antibodies Clinical Pipeline by Phase & Country
• Cancer Vaccine Clinical Pipeline by Phase & Country
• Oncolytic Viruses Clinical Pipeline by Phase & Country
• Cancer Cytokine Therapy Clinical Trial Insight by Phase & Country
• Cancer Cell Therapy Clinical Trial Insight by Phase & Country
• Currently there are 605 Cancer Monoclonal Antibodies, 289 Cancer Vaccines, 40 Oncolytic Viruses Drugs, 64 Cytokines Therapies & 82 Cell Therapies are in Clinical Pipeline

*** レポート目次(コンテンツ)***

1. Introduction to Cancer Immunotherapy (Page 6)

2. Mechanism of Cancer Immunotherapy (Page 11)
2.1 Genetic engineering
2.2 Hybridoma Technology
2.3 Humanization of Monoclonal Antibodies
2.4 Overcoming the HAMA Response via Modern Technology

3. Types of Cancer Immunotherapy (Page 14)
3.1 Monoclonal Antibodies
3.2 Checkpoint Inhibitors
3.3 Vaccination
3.4 Non Specific Immunotherapies

4. Why Need for Cancer Immunotherapy (Page 23)

5. Global Cancer Immunotherapy Market Overview (Page 26)

6. Cancer Immunotherapy Market Dynamics (Page 33)
6.1 Favorable Market Drivers
6.2 Key issues to be Discussed
6.3 Future of Cancer Immunotherapy

7. Cancer Monoclonal Antibodies Clinical Pipeline by Phase & Country (Page 41)
7.1 Clinical Pipeline Overview
7.2 Clinical Pipeline Insight: Research till Registration
7.3 Marketed Cancer Monoclonal Antibodies

8. Cancer Vaccine Clinical Pipeline by Phase & Country (Page 1088)
8.1 Clinical Pipeline Overview
8.2 Clinical Pipeline Insight: Research till Registration
8.3 Marketed Cancer Vaccines

9. Oncolytic Viruses Clinical Pipeline by Phase & Country (Page 1640)
9.1 Clinical Pipeline Overview
9.2 Clinical Pipeline insight: Research till Registration

10. Cancer Cytokine Therapy Clinical Trial Insight by Phase & Country (Page 1714)
10.1 Clinical Pipeline Overview
10.2 Clinical Pipeline Insight: Research till Preregistration
10.3 Marketed Cancer Cytokines Threapy

11. Cancer Cell Therapy Clinical Trial Insight by Phase & Country (Page 1844)
11.1 Clinical Pipeline Overview
11.2 Clinical Pipeline Insight: Research till Preregistration
11.3 Marketed Cancer Cell Therapy

12. Competitive Landscape: Business Overview & Product Pipeline (Page 1977)
12.1 Advaxis
12.2 Celldex Therapeutics
12.3 Dendreon Corporation
12.4 Galena Biopharma
12.5 ImmunoCellular Therapeutics
12.6 ImmunoGen
12.7 Inovio Pharmaceuticals
12.8 Merck
12.9 NeoStem Oncology
12.10 NewLink Genetics
12.11 Northwest Biotherapeutics
12.12 Novartis
12.13 Peregrine Pharmaceuticals
12.14 Roche
12.15 Seattle Genetics

List of Figures

Figure 1-1: Introduction to Cancer Therapies
Figure 1-2: Key Events in the History of Cancer Immunotherapy
Figure 2-1: Mechanism of Cancer Immunotherapy
Figure 3-1: Type of Cancer Immunotherapy

Figure 5-1: Cancer Immunotherapy Market Category
Figure 5-2: Cancer Immunotherapy Market (US$ Billion), 2014-2020
Figure 5-3: Cancer Immunotherapy Market by Region (%), 2014 & 2020
Figure 5-4: Regulatory Milestones for Cancer Immunotherapy

Figure 7-1: Cancer Monoclonal Antibodies Clinical Pipeline by Phase (%), 2014
Figure 7-2: Cancer Monoclonal Antibodies Clinical Pipeline by Phase (Number), 2014

Figure 8-1: Cancer Vaccine Clinical Pipeline by Phase (%), 2014
Figure 8-2: Cancer Vaccine Clinical Pipeline by Phase (Number), 2014

Figure 9-1: Oncolytic Viruses Clinical Pipeline by Phase (%), 2014
Figure 9-2: Oncolytic Viruses Clinical Pipeline by Phase (Number), 2014

Figure 10-1: Cancer Cytokines Therapy Clinical Pipeline by Phase (%), 2014
Figure 10-2: Cancer Cytokines Therapy Clinical Pipeline by Phase (Number), 2014

Figure 11-1: Cancer Cell Therapy Clinical Pipeline by Phase (%), 2014
Figure 11-2: Cancer Cell Therapy Clinical Pipeline by Phase (Number), 2014

Figure 12-1: Advaxis Clinical Pipeline
Figure 12-2: Celldex Therapeutics Clinical Pipeline
Figure 12-3: Galena Biopharma Clinical Pipeline
Figure 12-4: ImmunoCellular Therapeutics Clinical Pipeline
Figure 12-5: ImmunoGen Clinical Pipeline
Figure 12-6: Inovio Pharmaceuticals Clinical Pipeline
Figure 12-7: NewLink Genetics Corporation Clinical Pipeline
Figure 12-8: Northwest Biotherapeutics Clinical Pipeline
Figure 12-9: Peregrine Pharmaceuticals Clinical Pipeline
Figure 12-10: Seattle Genetics Clinical Pipeline



*** 掲載企業 ***

Advaxis,
Celldex Therapeutics,
Dendreon Corporation,
Galena Biopharma,
ImmunoCellular Therapeutics,
ImmunoGen,
Inovio Pharmaceuticals,
Merck,
NeoStem Oncology,
NewLink Genetics,
Northwest Biotherapeutics,
Novartis,
Peregrine Pharmaceuticals,
Roche,
Seattle Genetics


*** レポートのキーワード ***

がん免疫療法、免疫細胞療法、癌治療、単クローン抗体、チェックポイント抑制剤、予防接種

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • 世界のレオメータ市場2016
    The Global Rheometer Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Rheometer industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Rheomete …
  • 空港火災安全機器の世界市場
    Airport Fire Safety Equipment Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United …
  • 心肺ストレス検査システムの世界市場
    Cardiopulmonary stress testing is performed to evaluate exercise capacity and predict outcome in patients diagnosed with heart failure. The cardiopulmonary stress testing systems market report studies the current and future prospects of the market globally. The report comprises an elaborate executiv …
  • 世界のキャスター歩行器市場2015
    The Global Caster Rollator Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Caster Rollator industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Caster …
  • ゴム加工用化学品の世界市場:劣化防止剤、促進剤
    The rubber processing chemicals market is estimated to have accounted for 3.5 Billion in 2014 and is projected to reach 4.8 Billion by 2020, registering a CAGR of 5.4% between 2015 and 2020. The market is mainly driven by the growth in the automobile industry. Asia-Pacific is the fastest-growing veh …
  • 道路インフラ建設市場(~2018):中国
    This report is the result of Timetric’s extensive market research covering the road infrastructure construction industry in China. It contains detailed historic and forecast market value data for the road infrastructure construction industry, including a breakdown of the data by construction activit …
  • Cree, Inc. (CREE)(電力分野):企業M&A動向
    Summary Cree, Inc. (Cree) is a provider of lighting class LED's, LED lighting, and semiconductor solutions for wireless and power applications. It develops and manufactures semiconductor materials and devices principally based on silicon carbide (SiC), gallium nitride (GaN), and other related compou …
  • 米タンパク質濃縮物の世界市場
    Rice Protein Concentrate Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United State …
  • 自動車リースの世界市場
    About Car Leasing Leasing a car is a system of possessing a brand new or used car by paying to use it for a definite time. Many vendors offer a range of vehicles that can be leased by customers for a period as and when required. Leasing is similar to renting a car; however, the former is for a relat …
  • 世界及び中国のポータブル縄跳び市場2017
    The 'Global and Chinese Portable rope skipping Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Portable rope skipping industry with a focus on the Chinese market. The report provides key statistics on the market status of the Portab …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(KUK40723 )"世界におけるがん免疫療法及びパイプラインインサイト" (英文:Cancer Immunotherapy Market & Clinical Pipeline Insight)はKuick Research社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。